Back
Intra-Cellular Therapies Stock Price Chart
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.
Sell
35
ITCI
Intra-Cellular Therapies
Last Price:
75.57
Seasonality Move:
27.94%
7 Day Trial
ALL ACCESS PASS
$
7
The truth about AI stocks (must see)
Learn the names of all 10 stocks here. FREE.- The current trend is moderately bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
Intra-Cellular Therapies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.97 | Sell |
| 20-day SMA: | 74.13 | Buy |
| 50-day SMA: | 74.47 | Buy |
| 200-day SMA: | 71.42 | Buy |
| 8-day EMA: | 75.74 | Sell |
| 20-day EMA: | 74.93 | Buy |
| 50-day EMA: | 74.52 | Buy |
| 200-day EMA: | 70.81 | Buy |
Intra-Cellular Therapies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.56 | Buy |
| Relative Strength Index (14 RSI): | 49.99 | Sell |
| Chaikin Money Flow: | -206649 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.66 - 76.4) | Buy |
| Bollinger Bands (100): | (70.8 - 77.3) | Buy |
Intra-Cellular Therapies Technical Analysis
| Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intra-Cellular Therapies Stock
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 75.02 while ITCI 8-day simple moving average is 75.97, which is a Sell signal.
- The stock price of ITCI is 75.02 while Intra-Cellular Therapies 20-day SMA is 74.13, which makes it a Buy.
- Intra-Cellular Therapies 50-day simple moving average is 74.47 while ITCI share price is 75.02, making it a Buy technically.
- ITCI stock price is 75.02 and Intra-Cellular Therapies 200-day simple moving average is 71.42, creating a Buy signal.
ITCI Technical Analysis vs Fundamental Analysis
Sell
35
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy or a Sell?
-
Intra-Cellular Therapies stock is rated a Sell
The current Intra-Cellular Therapies [ITCI] share price is $75.02. The Score for ITCI is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Intra-Cellular Therapies Stock Info
Market Cap:
7.93B
Price in USD:
75.02
Share Volume:
269.86K
Intra-Cellular Therapies 52-Week Range
52-Week High:
84.89
52-Week Low:
45.50
Sell
35
Intra-Cellular Therapies (ITCI)
is a Sell
Intra-Cellular Therapies Share Price Forecast
-
What is the Intra-Cellular Therapies stock price today?
The Intra-Cellular Therapies stock price is 75.02 USD today. -
Will ITCI stock go up or go down?
Intra-Cellular Therapies> share price is forecast to RISE/FALL based on technical indicators -
Is Intra-Cellular Therapies overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intra-Cellular Therapies is overvalued.
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 75.02 while ITCI 8-day exponential moving average is 75.74, which is a Sell signal.
- The stock price of ITCI is 75.02 while Intra-Cellular Therapies 20-day EMA is 74.93, which makes it a Buy.
- Intra-Cellular Therapies 50-day exponential moving average is 74.52 while ITCI share price is 75.02, making it a Buy technically.
- ITCI stock price is 75.02 and Intra-Cellular Therapies 200-day simple moving average is 70.81, creating a Buy signal.
Fundamental Analysis of Intra-Cellular Therapies
Is Intra-Cellular Therapies a good investment?
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $1.12 per share.
Technical Analysis of Intra-Cellular Therapies
Should I short Intra-Cellular Therapies stock?
- ITCI Moving Average Covergence Divergence (MACD) indicator is 0.56, suggesting Intra-Cellular Therapies is a Buy
- Intra-Cellular Therapies Relative Strength Index (RSI) is 49.99, which suggest Intra-Cellular Therapies is oversold
- The Bollinger Bands (25) for Intra-Cellular Therapies is (72.66 - 76.4), which suggest Intra-Cellular Therapies is a Buy
- The Bollinger Bands (100) for Intra-Cellular Therapies is (70.8 - 77.3), which suggest Intra-Cellular Therapies is a Buy
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.